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Bioactive chemical constituents of Curcuma longa L. rhizomes 
extract inhibit the growth of human hepatoma cell line (HepG2)
The present study was designed to identify the chemical con-
stituents of the methanolic extract of Curcuma longa L. rhizo-
mes and their inhibitory effect on a hepatoma cell line. The 
metha nolic extract was subjected to GC-MS analysis to iden-
tify the volatile constituents and the other part of the same 
extract was subjected to liquid column chromatographic 
separation to isolate curcumin. The inhibition of cell growth 
in the hepa to ma cell line and the cytopathological changes 
were stu died. GC-MS analysis showed the presence of fifty 
compounds in the methanolic extract of C. longa. The major 
compounds were ar-turmerone (20.50 %), β-sesquiphellandrene 
(5.20 %) and curcumenol (5.11 %). Curcumin was identified 
using IR, 1H and 13C NMR. The inhibition of cell growth by cur-
cumin (IC50 = 41.69 ± 2.87 µg mL–1) was much more effec ti ve 
than that of methanolic extract (IC50 = 196.12 ± 5.25 µg mL–1). 
Dege ne rative and apoptotic changes were more evident in 
curcu min-treated hepatoma cells than in those treated with 
the meth anol extract. Antitumor potential of the methanolic 
extract may be attributed to the presence of sesquiterpenes and 
phenolic constituents including curcumin (0.051 %, 511.39 µg g–1 
dried methanol extract) in C. longa rhizomes.
Keywords: Curcuma longa L., GC-MS analysis, curcumin, anti-
cancer activity
Hepatocellular carcinoma (HCC) has recently acquired growing rates. HCC is respon-
sible for ~600,000 deaths annually worldwide (1, 2). This is related to various biological 
predisposing factors such as hepatitis B, hepatitis C and liver cirrhosis, all of which can 
progress into hepatocellular carcinoma (3). Many challenges exist in the current chemo-
therapeutic treatment approaches, including resistance, low selectivity and high toxic mar-
gins of current chemotherapeutics (4). This has called for the need to continuously explore 
new chemotherapeutics that would hopefully overcome the drawbacks of the currently 
existing therapy. Hence, a growing interest in exploring various natural herb products as 
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fruits, vegetables and spices have drawn attention of the scientific community due to their 
demonstrated ability to suppress cancers (6, 7). Many reports have shown that dietary 
agents and their active principles exerted cytotoxicity toward cancer cells (8).
Curcuma (family Zingiberaceae) is a genus containing 70 known species that has been 
his torically used as a spice, food preservative and coloring material. Curcuma longa L. is 
dis tributed throughout tropical and subtropical regions of the world. It is used in tra di tio-
nal medicine as a household remedy for various diseases. Also, it has been reported that 
C. longa possesses multiple pharmacological activities, including antioxidant, antimicrobial, 
anti -inflammatory, anti-carcinogenic, anticoagulant, antidiabetic and immunological ones 
(8, 9).
Terpenoids make a diverse class of pharmacologically active phytochemicals, in clud-
ing aromatic, non-aromatic, volatile and non-volatile constituents, which play a key role in 
tra ditional herbal remedies (10, 11). Among them, curcuminoids (diphenylheptanoids) in-
clu de curcumin and its derivatives, demethoxycurcumin and bisdemethoxycurcumin be ing 
the major bioactive compounds in C. longa. Curcuminoids are yellow natural phenols that 
have antioxidant, anticancer, anti-inflammatory and chemotherapeutic activities (12, 13).
The main objectives of the present work were to identify bioactive chemical consti tu-
ents of the crude methanolic extract of C. longa rhizomes using GC-MS, to isolate the major 
bioactive compound from the plant extract and to evaluate the potential of crude 
methanolic extract and curcumin on inhibition of the hepatoma cell line (HepG2) growth.
EXPERIMENTAL
General experimental procedures
Melting points were determined with a melting point apparatus SMP3 (Barloworld 
Scientific Ltd., UK). 1H NMR (500 MHz, DMSO-d6) and 13C NMR (125 MHz, DMSO-d6) 
spectra were recorded using Bruker 500 MHz (Bruker UK Ltd, UK) and JEOL-GX 270 
spectrometers (Akishima, Japan), resp. Chemical shifts were expressed in δ (ppm) as a 
reference TMS and coupling constant (J) in Hertz. UV spectra were determined in metha-
nol with a UV Spectronic 601 spectrophotometer (Milton Roy, USA). IR spectra (cm–1) were 
recorded on a Perkin-Elmer 1600 spectrometer (Perkin-Elmer, USA). Silica gel 60 GF254 
(Fluka, Switzerland) was used for analytical TLC. Sephadex LH-20 (25–100 µm, Sigma, 
USA) or silica gel (0.063–0.210 mm, Merck, Germany) were used for column chromatogra-
phy. Spots were visualized by spraying with ethanolic AlCl3 (2 %) or 10 % H2SO4 under UV.
Plant material
Dried rhizomes of Curcuma longa were purchased from a local herbal shop (Cairo, 
Egypt). The plant sample was identified and plant rhizomes were ground to fine powder 
with an electric mill for the extraction process.
Extraction and fractionation of C. longa rhizomes
Dried powder of C. longa rhizomes was extracted with 80 % methanol and then evapo-
rated under reduced pressure using rotatory evaporator. Dried methanolic extract was 
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defatted with petroleum ether and then fractionated with ethyl acetate (EtOAc) and evapo-
rated till dryness under reduced pressure. Crude methanolic extract and ethyl acetate 
fraction was kept away from moisture.
Phytochemical screening
Preliminary phytochemical screening of the crude methanolic extract of C. longa rhi-
zomes was carried out to estimate the amount of flavonoids, phenols, tannins, alkaloids, 
saponins, terpenoids and steroids according to the standard procedures (14, 15).
Gas chromatography-mass spectrometry (GC-MS) analysis
The crude methanolic extract of C. longa was diluted with methanol (1/100, V/V) and 
filtered. The particle-free diluted crude extract (1 μL) was taken in a syringe and injected into 
a GC-MS instrument with a split ratio 1:100. The analysis was carried out using a GC (Agilent 
7890A, Agilent Technologies, USA) interfaced with a mass-selective detector (MSD, Agilent 
7000, Agilent Technologies) equipped with a polar Agilent HP-5ms (5 %-phenyl methyl poly-
siloxane) capillary column (30 m × 0.25 mm i. d., 0.25-μm film thickness). The carrier gas was 
helium with the linear velocity of 1 mL min–1 at 210 °C. Identification of chemical compo-
nents was based on computer matching with NIST and WILEY libraries, as well as on com-
parison of the fragmentation pattern of the mass spectral data with those reported in the 
literature (16).
Chromatographic isolation of curcumin
Ethyl acetate fraction of C. longa was subjected to column chromatography (120×4 cm) 
packed with silica gel 60 (0.063–0.210 mm, Merck) as a stationary phase. Elution started 
with CHCl3, followed by CHCl3/MeOH and ended with pure methanol. Fractions were 
collected, concentrated and examined by TLC (silica gel, solvent system CHCl3/MeOH, 
19:1) and by PC (Whatman No. 1, solvent 15 % acetic acid). Chromatograms were visuali-
zed under UV before and after spraying with AlCl3. 
The major fraction was collected and re-chromatographed on another silica sub-col-
umn. Elution started with chloroform, mixtures of chloroform and methanol, ending with 
pure methanol. The sub-column fractions were monitored on a thin layer chromatography 
plate and using the solvent system CHCl3/MeOH (19:1). TLC were visualized by spraying 
with 10 % H2SO4 followed by heating at 110 °C. Fractions of similar chemical composition 
were collected and concentrated. The resulting fractions were further purified on a Sepha-
dex LH-20 column using H2O/MeOH (3:7). The major compound was purified on prepara-
tive TLC using CHCl3/MeOH (19:1) and crystallized with chloroform as orange powder.
High performance liquid chromatography (HPLC) analysis
Samples of C. longa (MeOH extract, EtOAc extract and curcumin) were dissolved in 1 
mL of HPLC grade MeOH, filtered using a filter membrane (pore size 0.45 μm, Phenex, 
USA) and centrifuged for 5 min at 6000 rpm before HPLC analysis.
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Samples were analyzed on a Shimadzu LC-8A liquid chromatography system (Shi-
madzu) with LC solution software, SPD-M20A photodiode array detector (Shimadzu). A 
RESTEK (5 µm) C18 column was used (4.6 mm i.d. × 150 mm). Elution was carried out with 
a gradient solvent system at a flow rate of 1 mL min–1. The mobile phase consisted of ace-
tonitrile (B) and 1 % formic acid in water (A). The LC time program was as follows: 5–20 % 
B (10 min), 20–30 % B (10 min), 30–50 % B (10 min), 50–98 % B (20 min), 98–98 % B (5 min) 
and 98–5 % B (5 min). The sample was injected into a volume of 20 µL and the eluate was 
monitored at 210 and 425 nm for detection of major chemical constituents in C. longa ex-
tracts.
The concentration of curcumin was calculated using the calibration curve of isolated 
curcumin with concentration ranging from 75 to 1000 µg mL–1. Regression coefficient for 
the curcumin calibration curve was 0.992 within this concentration range. The concentra-
tion of curcumin was expressed as µg g–1 in dry MeOH extract.
Cell culture
Human hepatocellular carcinoma HepG2 cell line (kindly provided by the Biology De-
partment of the American University in Cairo, Egypt) was used in testing the anticancer 
activity of the methanolic extract of C. longa and curcumin. Briefly, HepG2 cells were main-
tained in 75-cm3 culture flasks (Greiner bio-one GmbH, Germany) containing Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 4.5 g L–1 glucose and 10 g L–1 L-gluta-
mi ne (Bio Whittaker, Combrex Company, Belgium), 100 mL L–1 fetal calf serum (FCS), 10 g L–1 
penicillin/streptomycin and 1 g L–1 fungizone (250 mg L–1, Gibco-BRL Life Technologies, 
USA). The HepG2 cell line was cultured at 37 oC in a 5 % CO2 incubator for 72 hours. When 
the growth was in the confluence phase, the cell line was resuspensed from the culture flask 
by 0.025 % trypsin (Sigma) and the culture flask was gently shaken to ensure that a single-
cell suspension was obtained. Complete culture medium was renewed every 3 days and 
cells were passaged every 6–10 days. The exact cell count was recorded in 50 µL aliquots 
after mixing with an equal volume of trypan blue (5 g L–1, Biochrom KG, Berlin, Germany). 
The cells were counted using a Neubauer hemocytometer (Marienfeld, Germany). Cell via-
bility was tested by the trypan blue dye exclusion method (17).
Neutral red cytotoxicity assay
Neutral red cytotoxicity assay based on the initial protocol described by Repetto et al. 
(18) was carried out. Cells from the mother flask were seeded in a 24-well microtitre plate 
(Corning, USA) (1 × 106 cells per well). The plates were incubated at 37 oC in 5 % CO2 for 24 h 
to achieve monolayer confluence. Culture media containing different concentrations of the 
methanolic extract of C. longa and curcumin (15, 30, 60, 125, 250, 500, 1000 and 2000 µg mL–1) 
were added in triplicate. Medium without a sample acted as untreated control. The dye-
medium was removed and the plates were washed with PBS (pH = 7.4). Five hundred µL 
of acetic acid-ethanol (1 mL glacial acetic acid in 100 mL 50 % ethanol) was added and the 
plates were kept for 15 min at room temperature to extract the dye. They were then shaken 
for a few seconds so that complete dissolution was achieved. The absorbance of the ex-
tracted dye was measured using a 540 nm filter (Spectra max 190 Microplate Reader, Mo-
lecular Devices, USA). The inhibition percentage was calculated.
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Cytopathological diagnosis
The same population of cells was trypsinized and washed with phosphate buffered 
saline (pH = 7.4) and collected into a centrifuge tube. Collected sample was centrifuged at 
a rate of 1200–1500 rpm for 15 minutes using Shandon Cytospin (Thermo Fisher Scientific, 
USA). The sediment was smeared on slides pretreated with 3-amino-propyl-triethoxysa-
line (3-APTES, Sigma-Aldrich Ireland Ltd, Ireland). Slides were fixed immediately in 95 % 
ethanol for 24 hours and then stained with hematoxylin and eosin.
Data analysis
Experiments were carried out in triplicate and the data were presented as a mean ± 
standard error of the mean (SEM). Dose-response curves were plotted, and 50 % inhibitory 
concentration (IC50) was calculated using the Statistical Package for the Social Sciences 
(SPSS) for Windows 13.0.
RESULTS AND DICUSSION
Preliminary phytochemical screening
Preliminary phytochemical screening of the crude methanolic extract of C. longa rhi-
zo mes revealed the presence of a large amount of flavonoids, phenols and terpenoids. 
Also, a moderate amount of tannins, alkaloids, saponins and steroids was detected. On the 
other hand, Pawar et al. (19) and Gupta et al. (20) recently reported that terpenoids and 
curcuminoid compounds represent major components in the Curcuma species.
GC-MS analysis of C. longa rhizome methanolic extract
GC-MS analysis of the methanolic extract of C. longa showed the major chemical 
constituents shown in Table I and Figs. 1 and 3. Identification of the components of the 
extract was carried out based on their retention time (tR), molecular formula (MF), relative 
molecular mass (Mr) concentration (%) and mass fragmentation pattern. Our data showed 
a total of 50 compounds identified in the volatile part of methanolic extract. Major com-
pounds (in %) were ar-turmerone (20.50), β-sesquiphellandrene (5.20), curcuminol (5.11), 
2-methoxy-4-vinylphenol (4.32), cis-β-elemenone (3.98), isolongifolol (2.83), geranyl-p-
cumene (2.77), β-turmerone (2.58), β-curcumene (2.50), β-vatirenene (2.37), β-caryophyllene 
(2.27), α-curcumene (2.24), furanodiene (2.23), γ-curcumene (2.22), α-turmerone (1.84) and 
α-cedrene (1.80). These results revealed that the methanolic extract of C. longa rhizomes 
contains a mixture of compounds, especially sesquiterpene compounds such as 
germacrone, furanodiene, curcumene, turmerone, cedrene, curlone and β-elemene. Many 
of these compounds were major volatile components in essential oils and natural phyto-
chemicals of C. longa known to have many biological activities (21, 22).
Structure elucidation of curcumin
Curcumin was isolated by liquid column chromatography and proved to be water 
insoluble and methanol soluble [m.p. 185–187 °C (lit. m.p. 184–186 °C); IR nmax: 3425 (OH), 
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Table I. GC-MS analysis of methanolic extract of C. longa
Compd. tR Mr MF
Peak 
area (%) Compound name
1 3.70 134 C10H14 0.29 o-cymene                             
2 4.22 194 C12H18O2 1.58 L-trans-chrysanthenyl acetate
3 5.63 90 C4H10O2 0.51 DL-2,3-butanediol
4 5.78 166 C11H18O 0.83 5-isopropenyl-1,2-dimethylcyclohexan-2-enol       
5 8.73 134 C10H14 0.30 p-cymene                             
6 9.59 156 C10H20O 0.19 (2,4,6-triethylcyclohexyl)methanol
7 10.70 152 C10H16O 0.32 α-thujone
8 10.95 150 C11H18 0.19 2-ethenyl-1,1-dimenthyl-3-methylene-cyclohexane
9 11.11 152 C10H16O 0.47 cis-sabinol
10 11.64 152 C10H16O 0.68 cis-p-menth-2,8-dienol
11 12.06 150 C10H14O 0.23 2-isopropylidene-3-methylhexa-3,5-dienal     
12 12.19 150 C10H14O 0.25 thymol
13 12.39 150 C9H10O2 4.32 2-methoxy-4-vinyl phenol                                   
14 12.86 164 C10H12O2 0.26 m-eugenol
15 12.97 120 C9H12 0.35 hemellitol
16 13.05 176 C13H20 1.17 benzene-2-methyl-1,4-bis(1-methylethyl)
17 13.22 204 C15H24 2.50 β-curcumene
18 13.33 204 C15H24 1.80 α-cedrene
19 13.47 202 C15H22 2.22 γ-curcumene
20 13.54 204 C15H24 2.27 β-caryophyllene
21 13.63 202 C15H22 1.20 ar-curcumene
22 13.71 204 C15H24 0.31 β-himachalene
23 13.75 202 C15H22 2.24 α-curcumene
24 13.91 204 C15H24 0.29 β-elemene
25 14.07 204 C15H24 1.92 α-cubebene
26 14.18 204 C15H24 2.80 β-cedrene
27 14.32 204 C15H24 2.63 β-bisabolene
28 14.50 204 C15H24 5.20 β-sesquiphellandrene
29 14.67 220 C15H24O 0.19 cis-Z-α-bisabolene epoxide                    
30 14.77 202 C15H22 2.37 β-vatirenene
31 14.88 222 C15H26O 0.53 agarospirol
32 14.95 218 C15H22O 2.58 β-turmerone
33 15.02 218 C15H22O 0.29 curlone
34 15.19 218 C15H22O 1.90 germacrone
35 15.31 218 C15H22O 1.84 α-turmerone
36 15.38 216 C15H20O 1.55 curzerene
37 15.50 234 C15H22O2 0.21 dihydrocostunolide
38 15.63 216 C15H20O 2.23 furanodiene
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2927, 2853, 1627, 1600, 1508, 1464, 1427, 1275, 1202, 1182, 1105, 965 cm–1; 1H NMR (DMSO): 
9.68, 7.53 (d, J = 15.8 Hz, 2H), 7.29 (brs, 2H), 7.11 (dd, J = 8.0 Hz, 2H), 6.79 (d, J = 8.0 Hz, 2H), 
6.74 (d, J = 15.7 Hz, 2H), 3.94 ppm (s, 6H) ppm; 13C NMR (DMSO, 500 MHz): 183.74, 149.88, 
148.52, 141.24, 126.86, 123.65, 121.61, 116.23, 111.86, 101.59, 56.20 ppm].
IR spectrum indicated the presence of a hydroxyl group at 3425 cm–1, a carbonyl group 
at 1627 cm–1 and two bands at 1524 and 1509 cm–1 for aromatic double bonds (C=C). The 
1H NMR spectrum data of this compound exhibited two broad singlets at δ 6.79 and 7.53 ppm 
assigned to H-3/H-3′ and H-4/H-4′ protons, respectively. The ortho-coupled protons of the 
aromatic ring appeared as doublets at δ 6.79 and 7.11 ppm being assignable to H-9/H-9′ and 
H-10/H-10′, respectively. A singlet corresponding to two methoxy groups (OCH3) was 
observed at δ 3.94 ppm. This was confirmed by the presence of a signal at δ 56.20 ppm in the 
39 16.02 216 C15H20O 20.50 Ar-turmerone
40 16.17 234 C15H22O2 1.07 isocurcumenol
41 16.26 236 C15H24O2 0.87 curdione
42 16.34 234 C15H22O2 5.11 curcumenol
43 16.52 222 C15H26O 1.27 7-epi-cis-sesquisabinene hydrate
44 16.65 222 C15H26O 2.83 (–)-isolongifolol
45 16.78 242 C18H26 2.77 geranyl-p-cumene
46 16.89 218 C15H22O 3.98 cis-β-elemenone
47 16.97 220 C15H24O 1.78 isoshyobunone
48 17.19 234 C15H22O2 0.17 dihydrocostunolide
49 17.17 232 C15H20O2 1.72 dehydrosaussurea lactone
50 17.24 236 C15H24O2 1.84 corymbolone
Fig. 1. GC-MS chromatogram of C. longa rhizomes methanolic extract. The most abundant peaks: 2-me-
thoxy-4-vinylphenol (tR = 12.39 min), β-sesquiphellandrene (tR = 14.50 min), ar-turmerone (tR = 16.02 min), 
curcuminol (tR = 16.34 min), cis-β-elemenone (tR = 16.89 min)
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Fig. 2.  HPLC chromatogram of methanolic extract, ethyl acetate fraction and pure curcumin.
13C NMR spectrum. Also, the characteristic signals of other carbons of curcumin were 
observed in 13C NMR at 101.59 (C-1), 111.86 (C-6), 116.23 (C-9), 121.61 (C-3), 123.65 (C-10), 126.86 
(C-5), 141.24 (C-4), 148.52 (C-7), 149.88 (C-8) and 183.74 (C-2) ppm. Therefore, this compound 
was characterized as curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-
dione], as shown in Fig. 3 (23, 24).
HPLC-DAD fingerprint of C. longa extracts and pure curcumin
HPLC-DAD analysis of crude methanolic extract, ethyl acetate fraction and pure 
curcumin was performed at two wavelengths, 210 and 425 nm, as shown in Fig. 2. The 
methanolic extract exhibited several peaks at 210 nm, which revealed that it contained 
many phenolic compounds whereas three major peaks assigned to curcuminoid group 
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Fig. 3.  Structures of some compounds identified in C. longa rhizomes methanolic extract.
appeared at 425 nm with 40–42 min retention time in MeOH and EtOAc extracts. On the 
other hand, pure curcumin appeared at tR of 40 min with a concentration of 0.051 % (511.39 
µg g–1) in dry methanolic extract of C. longa rhizomes. These results are in full agreement 
with the previous studies, which reported that curcuminoids of curcuma species can be 
defined as phenolic compounds, including three compounds, namely curcumin (60–80 %), 
desmethoxycurcumin (15–30 %) and bisdesmethoxycurcumin (2–6 %) (24, 25).
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Fig. 4. Percentage inhibition of proliferation of HepG2 cell line for curcumin and methanolic extract 
of C. longa rhizomes (mean ± SD, n = 3).
Fig. 5. Cytospin smear stained with H&E (× 400) prepared from: a) untreated control HepG2 cells 
showing a large number of malignant hepatocytes forming sheets, clusters of cells with enlarged 
nuclei and increased nucleocytoplasmic ratio (arrow), b) HepG2 cell treated with pure curcumin 
showing a large number of small shrinking hepatocytes with central nuclei and with scattered apop-
totic changes (black arrow) with scattered (few) malignant hepatocytes (red/grey arrow). c) HepG2 
cell treatment with C. longa methanolic extract showing a moderate number of small shrinking hepa-
tocytes with central nuclei and with scattered apoptotic changes (red/grey arrow) with a small num-
ber of malignant  hepatocytes (black arrow).
Cytotoxicity assay and cytopathological changes
The present results show that both the methanolic extract of C. longa and curcumin itself 
induced cytotoxicity in the HepG2 cell line in a concentration dependent manner. The per-
cen ta ge of inhibition of cell viability of treated groups relative to untreated control is shown 
in Fig. 4. As expected, the IC50 value of pure curcumin was 41.69 ± 2.87 µg mL–1, while the 
analogous va lue for methanolic extract of C. longa rhizomes was 196.12 ± 3.98 µg mL–1.
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Concurrently, the cytotoxicity findings were confirmed by cytopathological changes 
in cytospin smear on the same cell population. Examination of smears prepared from 
HepG2 cells without treatment showed, using a light microscope, a large number of 
malignant polyhedrally-shaped hepatocytes forming acini and clusters of cells with 
enlarged nuclei and increased nucleocytoplasmic ratio.
HepG2 cell line cells treated with pure curcumin showed moderate to marked number 
of apoptotic cells; apoptotic changes appeared in the form of reduction in cell volume, cell 
shrinkage, reduction in chromatin condensation and formation of numerous clear cyto plas-
mic vacuoles and blebs. In addition, structural alterations of the degenerated cells with ne-
cro tic debris were observed, which were not seen in untreated HepG2 cells. Hepatoma cell 
line cells (HepG2) treated with the C. longa methanol extract showed a slight to moderate 
number of apoptotic cells, and degenerated cells as shown in Fig. 5.
Thus, in vitro cytotoxic activities induced by the C. longa methanolic extract and 
curcumin shown though cytopathological changes in the same cell population were 
comparable. The methanolic extract of C. longa induced inhibition of cell growth as well as 
apoptotic changes in the HepG2 cell line, which were attributed to the presence of multiple 
bioactive sesquitepenoidal and phenolic compounds in this extract. The isolated curcumin 
showed the same pattern of changes.
CONCLUSIONS
The results presented herein show that the methanolic extract of C. longa rhizomes 
contains a mixture of compounds especially sesquiterpenes and curcuminoids (especially 
curcumin) as major bioactive compounds. They exerted anticancer potential and induced 
inhibition of cell growth via apoptotic changes. Hence, the rhizomes of C. longa can be used 
as a natural source of anticancer substances and can serve as a source of quality raw 
material for pharmaceutical industries. This contributes to the scientific evidence for the 
use of this medicinal plant in traditional medicine.
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